As discussed earlier, iPSC-neurons from fAD patients show increased levels of phosphorylated tau [123], and two groups have shown a link between APP mutations and higher tau protein levels, suggesting a previously unidentified link between APP metabolism and tau proteostasis [71, 75]. Here, MAPT is linked to familial Alzheimer disease.